14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
GAIN vs CCAP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
GAIN Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 9–1 Matrix Metrics)
GAIN Overall Winner
6-Pillar Tally: GAIN 3 – 2 CCAP (1 Tie)
Matrix Metrics: GAIN 9 – 1 CCAP
As of Nov 16, 2026, Gladstone Investment Corporation (GAIN) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GAIN carries a Unified Composite Score of 39.9/100 (SELL) at $14.61 (16.8x Forward P/E, 94.4% operating margin), whereas CCAP carries 19.6/100 (STRONG SELL) at $10.08 (6.9x Forward P/E, 78.4% operating margin).
Defensive Composite Rating Caution: Although GAIN compares more favorably head-to-head, both GAIN (39.9/100 SELL) and CCAP (19.6/100 STRONG SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: GAIN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.7); meanwhile CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GAIN vs CCAP. Trailing 12-month operating profitability (GAIN 94.4% vs CCAP 78.4%) and valuation multiples (GAIN 16.8x vs CCAP 6.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Asset Management value chain with $582.6M market capitalization and 94.4% operating margin.
OpEx & R&D Reinvestment5.6% of Rev ($5.8M)
90D Engineering Disclosures0 Published
CCAP Moat ProfileHigh-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $373.2M market capitalization and 78.4% operating margin.
OpEx & R&D Reinvestment21.6% of Rev ($34M)
90D Engineering Disclosures0 Published
Investor FAQ GAIN vs CCAP Key Questions & Quantitative Answers
As of Nov 16, 2026, Gladstone Investment Corporation (GAIN) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GAIN carries a Unified Composite Score of 39.9/100 (SELL) at $14.61 (16.8x Forward P/E, 94.4% operating margin), whereas CCAP carries 19.6/100 (STRONG SELL) at $10.08 (6.9x Forward P/E, 78.4% operating margin). Defensive Composite Rating Caution: Although GAIN compares more favorably head-to-head, both GAIN (39.9/100 SELL) and CCAP (19.6/100 STRONG SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: GAIN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.7); meanwhile CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
GAIN leads the Growth & Scale pillar: GAIN posts +20.4% YoY revenue growth and +326.5% YoY earnings growth on $104M TTM revenue (100.0% gross margin, 94.4% operating margin), compared with CCAP at -15.5% YoY revenue growth and -14.9% YoY earnings growth on $156M TTM revenue (100.0% gross margin, 78.4% operating margin). On trailing 12-month operating scale, GAIN generates $104M in USD-normalized revenue versus $156M for CCAP. In operating R&D and SG&A reinvestment, GAIN deploys 5.6% of Rev ($5.8M) (0 90-day corporate R&D disclosures) versus 21.6% of Rev ($34M) (0 disclosures) for CCAP.
CCAP screens cheaper on headline valuation multiples. GAIN trades at 16.8x Forward P/E, 3.8x Trailing P/E, 5.41x PEG, and 5.6x EV/Revenue (unreported cash flow margin), whereas CCAP trades at 6.9x Forward P/E, 7.4x Trailing P/E, 0.89x PEG, and 2.4x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GAIN (29.2% ROE) versus CCAP (-0.5% ROE) capital efficiency.
In options market volatility and institutional positioning, GAIN carries 12.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.55β · 21% Vol realized risk). By comparison, CCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 50% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.